Barrier contraceptive method acceptability and choice are not reliable indicators of use

Sexually Transmitted Diseases

Volumn 30, Issue 7, 2003, Pages 556-561

  Minnis, Alexandra M ^a,b,c   Shiboski, Stephen C ^c   Padian, Nancy S ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9; SPERMICIDAL AGENT;

ADOLESCENT; ADULT; ARTICLE; CONDOM; CONTRACEPTION; DRUG FORMULATION; FEMALE; FILM; FOAM; GEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDY; REPRODUCTION; SEXUALLY TRANSMITTED DISEASE; SUPPOSITORY; UNITED STATES;

EID: 0038675341     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200307000-00005     Document Type: Article

References (26)

1. Joint United Nations Programme on HIV/AIDS, World Health Organization. AIDS Epidemic Update. December 2001. (http://www. unaids.org/worldaidsday/2001/Epiupdate2001/Epiupdate2001_en.pdf).
2. Maldonado M. Latinas and HIV/AIDS: implications for the 1990s. SIECUS Report 1990/91; 19(2):11-15.
3. Fort A. Investigation of the social context of fertility and family planning: a qualitative study in Peru. Int Fam Plann Perspect 1989; 15:88-95.
4. Heise LL, Elias C. Transforming AIDS prevention to meet women's needs: a focus on developing countries. Soc Sci Med 1995; 40:931-943.
5. Buvé A, Bishikwabo-Nsarhaza K, Mutangadura G. The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 2002; 359: 2011-2017.
6. McCormack S, Hayes R, Lacey CJN, Johnson AM. Microbicides in HIV prevention. BMJ 2001; 322:410-413.
7. Elias C, Heise L. Working Papers. The Development of Microbicides: A New Method of HIV Prevention for Women. New York: The Population Council, 1993.
8. Cates W, Stone KM. Family planning, sexually transmitted diseases and contraceptive choice: a literature update. Part I. Fam Plann Perspect 1992; 24:75-84.
9. Stein, Z. HIV prevention: an update on the status of methods women can use [editorial]. Am J Public Health 1993; 83:1379-1382.
10. Coggins C, Blanchard K, Friedland B. Men's attitudes toward a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reproductive Health Matters 2000; 8:132-141.
11. Darroch J, Frost J. Women's interest in vaginal microbicides. Fam Plann Perspect 1999; 31:16-23.
12. Eldridge G, St. Lawrence J, Little C, Shelby M, Brasfield T. Barriers to condom use and barrier method preferences among low-income African-Am women. Women Health 1995; 23:73-89.
13. Hardy E, Jimenez A, de Padua K, Zaneveld L. Women's preferences for vaginal antimicrobial contraceptives III: choice of a formulation. applicator, and packaging, Contraception 1998; 58:245-249.
14. Moon MW, Msizvo MT, Heiman JE, et al. Evaluation of the feasibility and acceptability of vaginal microbicides for the prevention of HIV/STI in Zimbabwe. National Academies of Practice Forum 2000; 2:135-139.
15. Allen S, Serufilira A, Carael M. Acceptability of condoms and spermicides in a population-based sample of urban Rwandan women [abstract 5137]. Presented at the 4th International Conference on AIDS. Stockholm, Sweden, 1988.
16. Minnis A, Padian N. Choice of female-controlled barrier methods among young women and their male sexual partners. Fam Plann Perspect 2001; 33:28-34.
17. Gollub E, French P, Latka M, Rogers C, Stein Z. Achieving safer sex with choice: studying a women's sexual risk reduction hierarchy in an STD clinic. Journal of Women's Health and Gender-Based Medicine 2001; 10:771-783.
18. Farr G, Gabelnick H, Sturgen K, Dorflinger L. Contraceptive efficacy and acceptability of the female condom. Am J Public Health 1994; 84:1960-1964.
19. Sinpisut P, Chandeying V, Skov S, Uahgowitchai C. Perceptions and acceptability of the female condom [Femidom] amongst commercial sex workers in the Songkla province, Thailand. Int J STD AIDS 1998; 9:168-172.
20. Ruminjo J, Steiner M, Joanis C, Mwathe E, Thagana N. Preliminary comparison of the polyurethane female condom with the latex male condom in Kenya. East Afr Med J 1996; 73:101-106.
21. Gollub E, Stein Z, El-Sadr W. Short-term acceptability of the female condom among staff and patients at a New York City hospital. Fam Plann Perspect 1995; 27:155-158.
22. Coggins C, Elias C, Atisook R, et al. Women's preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS 1998; 12:1389-1403.
23. Weir S, Feldblum P, Zekeng L, Roddy R. The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health 1994; 84:910-914.
24. Cook R, Rosenberg M. Do spermicides containing nonoxynol-9 prevent sexually transmitted infection? A meta-analysis. Sex Transm Dis 1998; 25:144-150.
25. Macaluso M, Demand M, Artz L, Hook ER. Partner type and condom use. AIDS 2000; 14:537-546.
26. Macaluso M, Demand M, Artz L, et al. Female condom use among women at high risk of sexually transmitted disease. Fam Plann Perspect 2000; 32:138-144.